The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Y-mAbs Therapeutics, Inc(NASDAQ:YMAB) 
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophag...
Website: http://www.ymabs.com
Founded: 2015
Full Time Employees: 65
Sector: Healthcare
Industry: Biotechnology
Y-mAbs Therapeutics Days Payable Outstanding ttm (DPO)
Y-mAbs Therapeutics Days Receivable Outstanding ttm (DSO)
Y-mAbs Therapeutics Days Inventory Outstanding ttm (DIO)
Y-mAbs Therapeutics Op Cashflow Per Share ttm
Y-mAbs Therapeutics Free Cashflow Per Share ttm
Y-mAbs Therapeutics Cash Per Share ttm
Y-mAbs Therapeutics P/S ratio ttm
Y-mAbs Therapeutics (GAAP) P/E ratio ttm
Y-mAbs Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.